Abbexa SARS-CoV-2抗原快速检测试剂盒简介
我们还提供专业使用的cov-19抗原检测试剂盒。这是一种用于实验室和医院检测的一次性体外诊断设备。这款包罗万象的套件仅需10分钟即可产生快速、直观的效果。
这是一种定性的横向流动免疫层析法，用于检测人口咽、鼻和鼻咽拭子中的SARSCoV-2抗原。
该盒含有与金纳米颗粒结合的抗SARS-CoV-2/COVID19单克隆抗体，金纳米颗粒与样本中存在的任何SARS-CoV-2抗原结合。抗SARS-CoV-2的单克隆抗体被包裹在硝化纤维素膜上的测试区域，该膜与抗原抗体复合物结合，并由于金纳米颗粒而形成彩色线。盒式磁带上端的控制区域确认测试是否成功。
读数应在C（控制）区域显示1行。根据接触冠状病毒的情况，G（IgG）和M（IgM）区域旁边可能出现紫色线。微弱的线条被视为阳性结果
SARS-CoV-2逆转录定量PCR试剂盒
Abbexa也很高兴向客户提供我们的qPCR套件。
严重急性呼吸综合征冠状病毒2（SARS-CoV-2/COVID19）RT-qPCR试剂盒，用于在单管中高效合成cDNA和实时PCR。
该试剂盒包含一组荧光探针引物，用于区分2019 nCoV/COVID19/SARS-CoV-2和SARS-CoV（bat SARS相关CoV）。SARS-CoV-2 RNA可在FAM通道中检测到，SARS-CoV RNA可在HEX、VIC或JOE通道中检测到（取决于所用设备）。
| COVID19 Kits | |||
| Catalogue Number | Product Name | Description | |
| abx365044 | Human SARS-CoV-2 Neutralizing Antibody ELISA Kit | For the qualitative detection of SARS-CoV-2/COVID19 Neutralizing Antibodies in Human serum and plasma. |
|
| abx365086 | Human SARS-CoV-2 Neutralizing Antibody ELISA Kit | For the semi-quantitative detection of SARS-CoV-2/COVID19 Neutralizing Antibodies in Human serum and plasma. |
|
| abx392294 | Human SARS-CoV-2 Nucleocapsid Protein IgG ELISA Kit | For the qualitative detection of SARS-CoV-2/COVID19 Nucleocapsid Protein IgG antibodies in Human serum and plasma. |
|
| abx392295 | Human SARS-CoV-2 Nucleocapsid Protein IgM ELISA Kit | For the qualitative detection of SARS-CoV-2/COVID19 Nucleocapsid Protein IgM antibodies in Human serum and plasma. |
|
| abx365028 | Human SARS-CoV-2 Spike Protein IgG ELISA Kit | For the qualitative detection of SARS-CoV-2/COVID19 Spike Protein IgG antibodies in Human serum and plasma. |
|
| abx365029 | Human SARS-CoV-2 Spike Protein IgM ELISA Kit | For the qualitative detection of SARS-CoV-2/COVID19 Spike Protein IgM antibodies in Human serum and plasma. |
|
| abx365085 | Human SARS-CoV-2 Spike Protein Total Antibody ELISA Kit |
For the qualitative detection of SARS-CoV-2/COVID19 Spike Protein total antibodies in Human serum and plasma. |
|
| abx365030 | SARS-CoV-2 Nucleocapsid Protein ELISA Kit | For the quantitative detection of SARS-CoV-2/COVID19 Nucleocapsid Protein in Hu- man serum, plasma and other biological fluids. |
|
| abx365031 | SARS-CoV-2 Spike Protein S1 RBD ELISA Kit | For the quantitative detection of SARS-CoV-2/COVID19 Spike Protein S1 RBD in Human tissue homogenates, cell lysates, cell culture supernatants, saliva, and other biological fluids. |
|
| Mutant SARS-CoV-2 Recombinant Proteins | |||
| Beta (South Africa) B.1.351 Variant – K417N, E484K and N501Y Mutations | |||
| The Beta (B.1.351) variant was first identified in South Africa. It contains the K417N, E484K and N501Y mutations in the spike protein’s receptor-binding domain. | |||
| Catalogue Number | Product Name | Description | |
| abx160085 | SARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant) |
Recombinant protein expressed in Insect cells. Tag: C-terminal His-tag. |
|
| abx620004 | SARS-CoV-2 Spike Protein RBD (Beta B.1.351 Variant) |
Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. |
|
| Gamma (Brazil) P.1 Variant – K417T, E484K and N501Y Mutations | |||
| The Gamma (P.1) variant was first identified in Brazil. It contains the K417T, E484K and N501Y mutations in the spike protein’s receptor-binding domain. | |||
| Catalogue Number | Product Name | Description | |
| abx160086 | SARS-CoV-2 S1 Protein RBD (Gamma P.1 Variant) |
Recombinant protein expressed in Insect cells. Tag: C-terminal His-tag. |
|
| abx620006 | SARS-CoV-2 Spike Protein RBD (Gamma P.1 Variant) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. |
|
| Epsilon (California) B.1.429/B.1.427 (CAL.20C) Variant – L452R Mutation | |||
| The L452R mutation is present in the B.1.429/B.1.427 (CAL.20C/Epsilon) variants first identified in California, USA. | |||
| Catalogue Number | Product Name | Description | |
| abx160087 | SARS-CoV-2 S1 Protein RBD (L452R Mutation) |
Recombinant protein expressed in Insect cells. Tag: C-terminal His-tag. |
|
| abx620007 | SARS-CoV-2 Spike Protein RBD (L452R Mutation) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. |
|
| Mutant SARS-CoV-2 Recombinant Proteins | |||
| India B.1.36 (AP) Variant — N450K Mutation | |||
| The N450K mutation is present in the B.1.36 variant first identified in Andhra Pradesh, India. | |||
| Catalogue Number | Product Name | Description | |
| abx620011 | SARS-CoV-2 Spike Protein RBD (N450K Mutation) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. |
|
| Kappa (India) B.1.617.1 Variant — E484Q and L452R Double-Mutation | |||
| The B.1.617 variant was first identified in India. It contains the E484Q and L452R mutations and is therefore widely known as a “double mutation” variant. These mutations have been reported to increase binding to human ACE2 and reduce antibody neutralization of the virus, in comparison with other variants. | |||
| Catalogue Number | Product Name | Description | |
| abx160088 | SARS-CoV-2 S1 Protein RBD (B.1.617 Variant) |
Recombinant protein expressed in Insect cells. Tag: His-tag. |
|
| abx620009 | SARS-CoV-2 Spike Protein RBD (B.1.617 Variant) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. |
|
| Delta (India) B.1.617.2 Variant — L452R and T478K Double-Mutation | |||
| The B.1.617.2 (Delta) variant was first identified in India. It contains the L452R and T478K mutations, which appear to increase viral infectivity compared with other variants. | |||
| Catalogue Number | Product Name | Description | |
| abx620012 | SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) |
Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. |
|
| Mutant SARS-CoV-2 Recombinant Proteins | |||
| Delta Plus B.1.617.2 (AY.1) Variant — K417N, L452R and T478K Mutations | |||
| The B.1.617.2.1 (Delta Plus) variant, also known as AY.1, contains the K417N mutation as well as the L452R and T478K mutations in the original B.1.617.2 (Delta) variant. These mutations appear to increase viral infectivity compared with other variants. | |||
| Catalogue Number | Product Name | Description | |
| abx620018 | SARS-CoV-2 Spike Protein RBD (Delta Plus B.1.617.2.1 Variant) |
Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. |
|
| Other Mutations | |||
| The E484K mutation is present in several variants, including those first identified in South Africa and Brazil. This mutation has been reported to reduce antibody neutralization of the virus. The S477N mutation has been reported to increase binding to human ACE2. |
|||
| Catalogue Number | Product Name | Description | |
| abx620005 | SARS-CoV-2 Spike Protein RBD (E484K Mutation) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. |
|
| abx620008 | SARS-CoV-2 Spike Protein RBD (S477N Mutation) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. |
|
| SARS-CoV-2 Antibody Pairs | |||
| Catalogue Number | Product Name | Description | |
| abx024239 | SARS-CoV-2/COVID19 Nucleocapsid Protein Antibody |
Mouse Monoclonal against SARS-CoV-2/ COVID19 NP (Capture Antibody) |
|
| abx024238 | SARS-CoV-2/COVID19 Nucleocapsid Protein Antibody |
Mouse Monoclonal against SARS-CoV-2/ COVID19 NP (Detection Antibody) |
|
| abx024240 | SARS-CoV-2/COVID19 Trimer- ic Spike 1 Protein Antibody |
Mouse Monoclonal against SARS-CoV-2/ COVID19 Trimeric S1 Protein (Capture Antibody) | |
| abx024241 | SARS-CoV-2/COVID19 Trimer- ic Spike 1 Protein Antibody |
Mouse Monoclonal against SARS-CoV-2/ COVID-9 Trimeric S1 Protein (Detection Antibody) | |
| abx243136 | SARS-CoV-2/COVID19 Spike Glycoprotein RBD Antibody Pair |
Contains a recombinant Llama with Human IgG1 Fc capture antibody, and recombinant Mouse with Human IgG1 Fc detection antibody. | |